Kingsview Wealth Management’s Avanos Medical AVNS Stock Holding History

Kingsview Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,455	Closed	-$318K	–	457
2019 Q1	$318K	Buy	7,455 +12	+0.2%	+$537	0.05%	340
2018 Q4	$333K	Buy	7,443 +212	+3%	+$11.1K	0.07%	270
2018 Q3	$495K	Hold	7,231	–	–	0.1%	229
2018 Q2	$414K	Hold	7,231	–	–	0.1%	219
2018 Q1	$333K	Sell	7,231 -5	-0.1%	-$237	0.08%	247
2017 Q4	$334K	Sell	7,236 -602	-8%	-$27.7K	0.12%	229
2017 Q3	$353K	Buy	7,838 +819	+12%	+$34.9K	0.16%	185
2017 Q2	$276K	Buy	+7,019	New	+$265K	0.14%	197

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Kingsview Wealth Management's AVNS Position: Q2 2019 in Review

Kingsview Wealth Management sold out of Avanos Medical (AVNS) in Q2 2019, closing a stake of 7,455 shares — an estimated $318K sold.

Kingsview Wealth Management first reported a position in AVNS in Q2 2017 and held it in 8 quarters. The position peaked at $495K in Q3 2018. 317 funds tracked by Wall St. Rank hold AVNS as of Q2 2019.

Kingsview Wealth Management reported no remaining Avanos Medical position as of Q2 2019 after selling out during the quarter.
Kingsview Wealth Management sold 7,455 Avanos Medical shares in Q2 2019, an estimated $318K.
Kingsview Wealth Management first reported a position in Avanos Medical in Q2 2017 and held it in 8 quarters.
Kingsview Wealth Management's Avanos Medical position peaked at $495K in Q3 2018.
317 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2019.

Based on Kingsview Wealth Management's 13F filing for Q2 2019, filed 29 Jan 2020.